Brief: Plx Pharma Inc Posts Q2 Loss Per Share $0.79
06/08/2021 12:01
Aug 6 (Reuters) - PLx Pharma Inc PLXP.O :
* REPORTS SECOND QUARTER 2021 RESULTS AND PROVIDES BUSINESS
UPDATE
* RECOGNIZED NO REVENUE FOR Q2 OF 2021 COMPARED TO $27,907
* Q2 LOSS PER SHARE $0.79
Source text for Eikon: ID:nGNX6c7fSp
Further company coverage: PLXP.O
((reuters.briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice